Fwd: CDC HIV/Hepatitis/STD/TB Prevention News Update 6/9/2014

---------- Forwarded message ----------
From: Prevention News <Prevention-News@cdcnpin.org>
Date: Mon, Jun 9, 2014 at 12:19 PM
Subject: CDC HIV/Hepatitis/STD/TB Prevention News Update 6/9/2014
To: iammejtm@gmail.com

Having trouble viewing this email? View it as a Web page. "PNU is a prevention and treatment news summary service. NPIN redistributes summaries as a public service. Inclusion of an article does not constitute CDC endorsement of the content. More details in footer." NOTICE Due to a reduction in funding and competing government priorities the daily CDC HIV/AIDS, Viral Hepatitis, STD and TB Prevention News Update (PNU) service is being discontinued as of June 30, 2014. Between now and June 30, the PNU frequency will change to three times per week. While the government understands the convenience of this service for our stakeholders we hope that you will be able to utilize one of the available news alerts from search engines such as Google and Yahoo to receive disease specific news. 6/9/2014 National News USPSTF Urges HBV Screening for High-Risk People International News Haiti Reports 25000 New HIV Cases in 2013 Medical News Japanese HCV-Infected Patients Met SVR with Daclatasvir, Asunaprevir Local and Community News Jerusalem House Offers Stability to Homeless Affected by HIV/AIDS News Briefs Indiana Inmate Tests Positive for Tuberculosis Summers County Tackles Serious Issues with the Help of WVU School of Public Health National News USPSTF Urges HBV Screening for High-Risk People UNITED STATES :: Viral Hepatitis MedPage Today (05.27.2014) :: By Michael Smith Medpage Today reported that the US Preventive Services Task Force (USPSTF) has recommended hepatitis B virus (HBV) testing for individuals at high risk of contracting the disease. This recommendation represents a change from USPSTF's 2004 position against screening and an expansion of its 2009 position that recommended prenatal screening for pregnant women only. The present focus is on asymptomatic, nonpregnant adolescents and adults who fall into high-risk categories. Health experts welcome the upgraded recommendations and say they are long overdue. CDC, the American Association for the Study of Liver Diseases, and the Institute of Medicine have recommended testing of high-risk groups for some time. USPSTF detailed the high-risk categories to be: persons born in countries where the prevalence of HBV infection is 2 percent or higher; US-born citizens who were not vaccinated in infancy, but whose parents were from a high HBV prevalence country; persons with HIV; injection drug users; people living in the same household with people who have HBV; and men who have sex with men. USPSTF noted that between 700,000 and 2.2 million Americans have chronic HBV and estimates that between 15 and 25 percent of those people will die from cirrhosis or liver cancer. Those with chronic HBV also can transmit the disease to others, and screening will help people make treatment choices or other prevention choices. New HBV treatment therapies now exist and recent research indicates that immunoprophylaxis given to HBV-positive pregnant women can prevent vertical transmission of the disease to the newborn. The full report, "Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: U.S. Preventive Services Task Force Recommendation Statement," was published online in the Annals of Internal Medicine (2014; doi: 10.7326/M14-1018). Read Full Article Share this Article Back to Top International News Haiti Reports 25000 New HIV Cases in 2013 HAITI :: HIV/AIDS Global Dispatch (06.08.2014) :: By Robert Herriman The Global Dispatch reported that Haiti recorded more than 25,000 new HIV diagnoses in 2013, which accounts for 12 percent of the total cases reported from 2000 to 2013. The majority of new HIV cases were among women at a ratio of 1.7:1, which is consistent with recent patterns. Approximately 20 percent of infected women also were pregnant. The highest HIV prevalence by age group was among adults in their 30s, followed by adults in their 40s, then adults in between 25 and 29 years old. Eleven percent of reported HIV infections were in children 14 years old and younger. More than 60 percent of infections were among heterosexuals for both men and women, while only 6 percent was reported among men who have sex with men. Condom usage was low, with only 16 percent of men and 17 percent of women reported using them regularly. Fewer than 10 percent of men and women reported knowingly having sex with a person with HIV. Read Full Article Share this Article Back to Top Medical News Japanese HCV-Infected Patients Met SVR with Daclatasvir, Asunaprevir JAPAN :: Viral Hepatitis Healio (06.04.2014) Healio reported on a phase 3 trial of two antiviral drugs for treating chronic hepatitis C virus (HCV) genotype 1b infection. In a multiclinical trial, Japanese researchers tested dual therapy with daclatasvir and asunaprevir to treat 222 patients (median age 62.5 years; 65.3 percent women) with chronic HCV 1b who were not successful with previous therapies. The researchers separated participants into two groups, with 135 individuals forming the interferon-ineligible/intolerant group and 87 nonresponders. Participants received 60 milligrams (mg) daclatasvir once daily and 100 mg asunaprevir twice a day for 24 weeks. Results show that 87.4 percent of participants in the interferon-ineligible/intolerant group achieved sustained virologic response (SVR) at 24 weeks and 89.6 percent completed therapy. In the nonresponder group, 80.5 percent experienced SVR and 83.9 percent completed treatment. Of each group, 14 patients dropped out due to adverse effects, lack of efficacy, or at personal request; 5.9 percent of all patients experienced serious adverse effects. The researchers concluded that the 24-week ribavirin-free all-oral treatment using daclatasvir and asunaprevir showed high rates of SVR in these participants with HCV genotype 1b. The full report, "Daclatasvir Plus Asunaprevir for Chronic HCV Genotype 1b Infection," was published in the journal Hepatology (2014; 59(6): 2083–2091; doi: 10.1002/hep.27113). Read Full Article Share this Article Back to Top Local and Community News Jerusalem House Offers Stability to Homeless Affected by HIV/AIDS GEORGIA :: HIV/AIDS Atlanta INtown Paper (06.06.2014) :: By Clare S. Richie Atlanta INTown Paper reported on Jerusalem House, which has provided housing support for homeless and low-income men women and children affected by HIV/AIDS for 25 years. When Jerusalem House began in 1989 with five housing units, it provided AIDS patients a safe place to die with dignity. At present, Jerusalem House, with the help of partners from the Atlanta community including Southern Bell, the Community Foundation for Greater Atlanta, and the Woodruff Foundation, is a place of stability and hope with 140 furnished units serving approximately 240 individuals daily, including more than 100 children. It is Atlanta's largest provider of permanent supportive housing for this population. Jerusalem House leases two properties in the Druid Hills neighborhood—one for single adults and one for single mothers and their children—and leases a block of apartments for adults and families. Residents create a plan leading to living on their own eventually, and receive case management, meals, counseling, budgeting classes, healthcare, and other needs. The program offers homework assistance at its learning center and supplies onsite counseling through its partners. Charlie Frew, executive director of Jerusalem House, explained that the program would like more permanent facilities. Its goal is to own instead of rent, because of the difficulty for government-funded programs to keep up with rental increases. In addition, residential facilities will allow the program to provide more supportive services. Read Full Article Share this Article Back to Top News Briefs Indiana Inmate Tests Positive for Tuberculosis INDIANA :: TB WTHR-TV (Indianapolis) (06.08.2014) WTHR.com reported that an inmate at the central Indiana Pendleton Correctional Facility has tested positive for active TB. According to the Indiana State Department of Health and Indiana Department of Corrections (IDOC), the individual has been transferred to the Miami Correctional Facility and has begun treatment. The facility will screen inmates and staff who came into contact with the individual during the infectious period. Those who test negative will be retested again in 10 weeks; those who test positive will receive follow-up testing to determine whether they have active or latent TB and begin treatment. Since there is an increased risk of communicable diseases in a correctional setting, IDOC follows an aggressive TB control plan for screening and treatment, with facility staff undergoing screening annually and inmates being screened for symptoms upon intake. Indiana reported 102 TB cases for 2012 and 94 cases in 2013. Read Full Article Share this Article Back to Top   Summers County Tackles Serious Issues with the Help of WVU School of Public Health WEST VIRGINIA :: Viral Hepatitis WVNSTV.com (Ghent, W. Va.) (06.06.2014) :: By Jessica Schueler WVNSTV.com reported that Dr. David Parker, associate professor of epidemiology at West Virginia University's (WVU) School of Public Health, visited Hinton, West Va., on June 6 to meet with community leaders, clinics, and the local hospital in efforts to examine underlying problems with drugs and infectious diseases in the area. He commented that West Virginia ranks highest in the nation for the hepatitis B virus, and Summers County ranks in the top three counties within the state for the highest number of viral hepatitis cases. Parker said that WVU's School of Public Health is looking specifically at hepatitis, drug use, and drug overdoses, and he is working with the state's Bureau of Public Health to apply for CDC grants that will provide training to local physicians in how to treat viral hepatitis. Another grant in the works for Summers County will look at risk factors related to drug use in the county. Read Full Article Share this Article Back to Top The CDC National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention provides the above information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, viral hepatitis, other sexually transmitted diseases, and tuberculosis does not constitute CDC endorsement. The above summaries were prepared without conducting any additional research or investigation into the facts and statements made in the articles being summarized, and therefore readers are expressly cautioned against relying on the validity or invalidity of any statements made in these summaries. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/Hepatitis/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted above for full texts of the articles. The Prevention News Update electronic mailing list is maintained by the National Prevention Information Network (NPIN), part of the Centers for Disease Control and Prevention's National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Regular postings include the Prevention News Update, select articles from the Morbidity and Mortality Weekly Report series, and announcements about new NPIN products and services. Questions? Contact Us STAY CONNECTED: SUBSCRIBER SERVICES: Manage Preferences  |  Unsubscribe  |  Help

--
Jeremy Tobias Matthews